Vertex Pharmaceuticals Inc (VRTX)
408.18
+2.91
(+0.72%)
USD |
NASDAQ |
Dec 24, 16:00
Vertex Pharmaceuticals Free Cash Flow: -1.352B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Gilead Sciences Inc | 9.431B |
| Bristol-Myers Squibb Co | 13.80B |
| Pfizer Inc | 8.227B |
| PTC Therapeutics Inc | -274.19M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.370B |
| Cash from Investing (Quarterly) | -348.00M |
| Cash from Financing (Quarterly) | -387.50M |
| Free Cash Flow Per Share (Quarterly) | 4.989 |
| Free Cash Flow to Equity (Quarterly) | 1.302B |
| Free Cash Flow to Firm (Quarterly) | 1.302B |
| Free Cash Flow Yield | -1.27% |